Last reviewed · How we verify

NCT03080389

Sensitivity of Extended Cultures in Diagnosing Urinary Tract Infections

Terminated Last updated 4 September 2018
What this trial tests

trial testing Extended Urine Culture in Overactive Bladder in 16 participants. Terminated before completion.

Timeline
1 July 2017
Primary endpoint
1 August 2018
1 August 2018

Quick facts

Lead sponsorThe Cleveland Clinic
StatusTerminated
Study typeOBSERVATIONAL
Enrollment16
Start date1 July 2017
Primary completion1 August 2018
Estimated completion1 August 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The Cleveland Clinic

Who can join

Adults 18 to 70, female only, with Overactive Bladder or Overactive Detrusor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is some evidence to suggest standard urine cultures may not be adequate in identifying patients with low grade urinary tract infections. Therefore, there are patients with symptoms of frequency and urgency, being misdiagnosed with overactive bladder due to negative urine cultures. If this is true, could extended cultures be used to identify the false negative patients?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Overactive Bladder

Currently open trials in the same condition.

Other The Cleveland Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03080389.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing